Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen

Infection and Immunity

Volumn 71, Issue 1, 2003, Pages 374-383

  Grosfeld, Haim ^a   Cohen, Sara ^a   Bino, Tamar ^a   Flashner, Yehuda ^a   Ber, Raphael ^a   Mamroud, Emanuelle ^a   Kronman, Chanoch ^a   Shafferman, Avigdor ^a   Velan, Baruch ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; DNA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; FEMALE; GENE GUN; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLAGUE; PRIORITY JOURNAL; RNA TRANSLATION; SEMLIKI FOREST ALPHAVIRUS; YERSINIA PESTIS;

ANIMALS; ANIMALS, OUTBRED STRAINS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL PROTEINS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; PLAGUE; PLAGUE VACCINE; PLASMIDS; TRANSFECTION; VACCINES, DNA; YERSINIA PESTIS;

EID: 0037222453     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.1.374-383.2003     Document Type: Article

References (41)

1. Abramov, V. M., A. M. Vasiliev, R. N. Vasilienko, N. L. Kulokova, I. V. Kosarev, V. S. Khlebnikov, A. T. Ishchenko, S. MacIntyre, J. L. Gillespie, R. Kurana, T. Korpela, A. L. Fink, and V. N. Uversky. 2001. Structural and functional similarity between Y. pestis capsular protein Caf1 and human interleukin-1β. Biochemistry 40:6076-6084.
2. Anderson, G. W., D. G. Heath, C. R. Bolt, S. L. Welkos, and A. M. Friedlander. 1998. Short and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58:793-799.
3. Andrews, G. P., D. G. Heath, G. W. Anderson, Jr., S. L. Welkos, and A. M. Friedlander. 1996. Fraction 1 capsular antigen purification from Yersinia pestis CO92 and from an E. coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 64:2180-2187.
4. Baker, E. E., H. Sommer., L. E. Foster, E. Meyer, and K. F. Meyer. 1952. Studies on immunization against plague. I. Isolation and characterization of the soluble antigen of Pasteurella pestis. J. Immunol. 68:131-145.
5. Ben-Gurion, R., and I. Hertman. 1958. Bacteriocin-like material produced by Pasteurella pestis. J. Gen. Microbiol. 19:289-297.
6. Bennett, A. M., R. J. Phillpotts, S. D. Perkins, S. C. Jacobs, and E. D. Williamson. 1999. Gene gun mediated vaccination is superior to manual delivery for immunization with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus. Vaccine 18: 588-596.
7. Bennett, L. G., and T. G. Tornabene. 1974. Characterization of the antigenic subunits of the envelope protein of Yersinia pestis. J. Bacteriol. 117:48-55
8. Boyle, J. S., C. Koniaras, and A. M. Lew. 1997. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: Cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol. 9:1897-1906.
9. Brandler, P., K. U. Sakh, D. Heath, A. Friedlander, and R. G. Urlich. 1998. Weak anamnestic responses of inbred mice to Yersinia genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive. J. Immunol. 161:4195-4200.
10. Cohen, A. D., J. D. Boyer, and D. B. Weiner. 1998. Modulating the immune response to genetic immunization. FASEB J. 12:1611-1626.
11. Davis, H. L., and M. J. McCluskie. 1999. DNA vaccines for viral diseases. Microbes Infect. 1:7-21.
12. Davis, K. M., D. L. Fritz, L. M. Pitt, S. L. Welkos, P. L. Worsham, and A. M. Friedlander. 1996. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys. Arch. Pathol. Lab. Med. 120:156-163.
13. Du, Y., R. Rosqvist, and A. Forsberg. 2002. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect. Immun. 70:1453-1460.
14. Elvin, S. J., and E. D. Williamson. 2000. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses. Microb. Pathog. 29:223-230.
15. Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:2278-2284.
16. Galyov, E. E., O. Y. Smirnov, A. V. Karlishev, K. I. Volkovoy, A. I. Denesyuk, I. V. Nazimov, K. S. Rubstov, V. M. Abramov, S. M. Dalvadyanz, and V. P. Zav'yalov. 1990. Nucleotide sequence of Yersinia pestis gene encoding F1 antigen and the primary structure of the protein. FEBS Lett. 277:230-232.
17. Garoff, H., C. Kondor-Koch, R. Petterson, and B. Burke. 1983. Expression of Semliki Forest virus proteins from cloned cDNA. J. Cell Biol. 97:652-658.
18. Gregersen, J. P. 2001. DNA vaccines. Naturwissenschaften 88:504-513.
19. Grosfeld, H., B. Velan, M. Leitner, S. Lustig, B.-E. Lachmi, and A. Shafferman. 1989. Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge. J. Virol. 63:3416-3422.
20. Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: Immunology, application, and optimization. Annu. Rev. Immunol. 18:927-974.
21. Kerem, A., C. Kronman, S. Bar-Nun, A. Shafferman, and B. Velan. 1993. Interrelations between assembly and secretion of recombinant human acetylcholinesterase. J. Biol. Chem. 268:180-184.
22. Marshall, J. D., P. J. Bartelloni, D. C. Cavanaugh, P. J. Kadull, and K. F. Meyer. 1974. Plague immunization. II. Relation to adverse clinical reactions to multiple immunizations with killed vaccine. J. Infect. Dis. 129:S19-S25.
23. Meyer, K. F. 1970. Effectiveness of live or killed plague vaccines in man. Bull. W. H. O. 42:653-666.
24. Meyer, K. F., J. A. Hightower, and F. R. McCrumb. 1974. Plague immunization. VI. Vaccination with the fraction 1 antigen of Yersinia pestis. J. Infect. Dis. 129:S41-S45
25. Plemper, R. K., and D. E. Wolf. 1999. Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem. Sci. 24:266-270.
26. Reyes, A., and H. C. J. Ertl. 2001. DNA vaccines. Curr. Mol. Med. 1:217-243.
27. Saikh, K. U., J. Sesno, P. Brandler, and R. G. Ulrich. 1998. Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case. Vaccine 16:1029-1038.
28. Schlesinger, M. J., and S. Schlesinger (ed.). 1986. Formation and assembly of alphavirus glycoproteins, p. 121-148. In The Togaviridae and Flaviviridae. Plenum Press, New York, N.Y.
29. Simpson, W. J., R. E. Thomas, and T. G. Schwan. 1990. Recombinant capsular antigen from Yersinia pestis induces a protective antibody response in BALB/c mice. Am. J. Trop. Med. Hyg. 43:389-396.
30. Snapper, C. M., F. D. Finkelman, and W. E. Paul. 1988. Differential regulation of IgG1 and IgE by synthesis of interleukin 4. J. Exp. Med. 167:183-197.
31. Tito, M. A., J. Miller, K. F. Griffin, E. D. Williamson, R. W. Titball, and C. V. Robinson. 2001. Macromolecular organization of the Yersinia pestis capsular F1 antigen: Insight from time-of-flight mass spectrometry. Protein Sci. 10: 2408-2413.
32. Torres, C. A. T., K. Yang, F. Mustafa, and H. R. Robinson, 1999. DNA immunization: Effect of secretion of DNA-expressed hemagglutinins on antibody responses. Vaccine 18:805-814.
33. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felger, V. J. Dwarki, S. H. Gromkoowski, R. R. Deck, C. M. DeWitt, A. Freidman, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
34. Velan, B., H. Grosfeld, C. Kronman, Y. Gozes, A. Lazar, Y. Flashner, D. Marcus, S. Cohen, and A. Shafferman. 1991. The effect of elimination of intrasubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. J. Biol. Chem. 266:23977-23984.
35. Vorontsov, E. D., A. G. Dubichev, L. N. Serdobintsev, and A. V. Naumov. 1990. Association-dissociation processes and supermolecular organization of the capsule antigen (protein F1) of Yersinia pestis. Biomed. Sci. 1:391-396.
36. Weiss, R. W., J. Durnberger, S. Mostbock, S. Scheiblhofer, A. Hartl, M. Breitenbach, P. Strasser, F. Dorner, I. Livey, B. Crowe, and J. Thalhamer. 1999. Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence. Vaccine 18:815-824.
37. Welkos, S. L., K. M. Davis, L. M. Pitt, P. L. Worsham, and A. M. Friedlander. 1995. Studies on the contribution of the F1-capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib. Microbiol. Immunol. 13:299-305.
38. Williamson, E. D., M. E. Stephen, K. F. Griffin, M. Green, P. Russel, S. E. C. Leary, P. C. F. Oyston, T. Easterbrook, K. M. Reddin, A. Robinson, and R. W. Titball. 1995. A new improved sub-unit vaccine for plague: The basis of protection. FEMS Immunol. Med. Microbiol. 12:223-230.
39. Williamson, E. D., S. M. Eley, A. J. Stagg, M. Green, P. Russell, and R. W. Titball. 1997. A sub-unit vaccine elicits IgG in serum, spleen cell culture and bronchial washing and protects immunized animals against pneumonic plague. Vaccine 15:1079-1084.
40. Williamson, E. D., P. M. Vesey, K. J. Gillhespy, S. M. Eley, M. Green, and R. W. Titball. 1999. An IgG1 titer to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116:107-114.
41. Williamson, E. D., A. M. Bennett, S. D. Perkins, R. J. Beedham, J. Miller, and L. W. J. Baillie. 2002. Co-immunization with a plasmid DNA cocktail primes mice against anthrax and plague. Vaccine 20:2933-2941.